| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 13 |
| 1 | FLUOXETINE | 11 |
| 2 | FLUOXETINE HYDROCHLORIDE | 11 |
| 3 | LORAZEPAM | 11 |
| 4 | CYTARABINE | 9 |
| 5 | METHOTREXATE SODIUM | 9 |
| 6 | ALCOHOL | 8 |
| 7 | ETHYL ALCOHOL | 8 |
| 8 | ISOPROPYL ALCOHOL | 8 |
| 9 | LEUCOVORIN CALCIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAUNORUBICIN HYDROCHLORIDE | 5 | 0.0030 |
| 1 | THIOGUANINE | 1 | 0.0005 |
| 2 | LEUCOVORIN CALCIUM | 8 | 0.0004 |
| 3 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 4 | ETHYL ALCOHOL | 8 | 0.0003 |
| 5 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 6 | ISOPROPYL ALCOHOL | 8 | 0.0002 |
| 7 | ALCOHOL | 8 | 0.0002 |
| 8 | CALCIUM CARBONATE, SIMETHICONE | 1 | 0.0002 |
| 9 | CYTARABINE | 9 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 13 |
| 1 | Corticosteroid [EPC] | 13 |
| 2 | Benzodiazepine [EPC] | 12 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 10 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 8 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 8 |
| 7 | Alkylating Drug [EPC] | 7 |
| 8 | Estrogen [EPC] | 4 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Alkaloid [EPC] | 1 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 10 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 10 | 0.0000 |
| 8 | Atypical Antipsychotic [EPC] | 13 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 7 | 0.0000 |